image
Technology - Software - Application - NASDAQ - BE
$ 5.59
0 %
$ 330 M
Market Cap
30.5
P/E
1. INTRINSIC VALUE

This DCF valuation model was last updated on Jun, 6, 2025.

The intrinsic value of one MTLS stock under the worst case scenario is HIDDEN Compared to the current market price of 5.59 USD, Materialise NV is HIDDEN

This DCF valuation model was last updated on Jun, 6, 2025.

The intrinsic value of one MTLS stock under the base case scenario is HIDDEN Compared to the current market price of 5.59 USD, Materialise NV is HIDDEN

This DCF valuation model was last updated on Jun, 6, 2025.

The intrinsic value of one MTLS stock under the best case scenario is HIDDEN Compared to the current market price of 5.59 USD, Materialise NV is HIDDEN

2. FUNDAMENTAL ANALYSIS

Price Chart MTLS

image
$10.0$10.0$9.0$9.0$8.0$8.0$7.0$7.0$6.0$6.0$5.0$5.0$4.0$4.015 Dec15 DecJan '25Jan '2515 Jan15 JanFeb '25Feb '2515 Feb15 FebMar '25Mar '2515 Mar15 MarApr '25Apr '2515 Apr15 AprMay '25May '2515 May15 MayJun '25Jun '25
FINANCIALS
267 M REVENUE
4.15%
9.43 M OPERATING INCOME
67.86%
13.4 M NET INCOME
103.61%
31.5 M OPERATING CASH FLOW
56.05%
-28.6 M INVESTING CASH FLOW
-159.02%
-27.6 M FINANCING CASH FLOW
-23.59%
66.4 M REVENUE
1.06%
574 K OPERATING INCOME
145.27%
-535 K NET INCOME
-18.41%
9.71 M OPERATING CASH FLOW
56.23%
-1.76 M INVESTING CASH FLOW
76.68%
-5.83 M FINANCING CASH FLOW
53.59%
Balance Sheet Materialise NV
image
Current Assets 191 M
Cash & Short-Term Investments 102 M
Receivables 53.1 M
Other Current Assets 35.2 M
Non-Current Assets 206 M
Long-Term Investments 3.99 M
PP&E 119 M
Other Non-Current Assets 82.8 M
25.81 %13.39 %8.87 %30.04 %20.89 %Total Assets$396.3m
Current Liabilities 102 M
Accounts Payable 23.3 M
Short-Term Debt 13 M
Other Current Liabilities 65.8 M
Non-Current Liabilities 45.7 M
Long-Term Debt 28.3 M
Other Non-Current Liabilities 17.4 M
15.79 %8.79 %44.53 %19.13 %11.75 %Total Liabilities$147.8m
EFFICIENCY
Earnings Waterfall Materialise NV
image
Revenue 267 M
Cost Of Revenue 116 M
Gross Profit 151 M
Operating Expenses 141 M
Operating Income 9.43 M
Other Expenses -3.97 M
Net Income 13.4 M
300m300m250m250m200m200m150m150m100m100m50m50m00267m(116m)151m(141m)9m4m13mRevenueRevenueCost Of RevenueCost Of RevenueGross ProfitGross ProfitOperating ExpensesOperating ExpensesOperating IncomeOperating IncomeOther ExpensesOther ExpensesNet IncomeNet Income
RATIOS
56.54% GROSS MARGIN
56.54%
3.54% OPERATING MARGIN
3.54%
5.04% NET MARGIN
5.04%
5.41% ROE
5.41%
3.39% ROA
3.39%
2.91% ROIC
2.91%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis Materialise NV
image
15m15m10m10m5m5m00(5m)(5m)(10m)(10m)(15m)(15m)(20m)(20m)(25m)(25m)20162016201720172018201820192019202020202021202120222022202320232024202420252025
Net Income 13.4 M
Depreciation & Amortization 21.8 M
Capital Expenditures -26.4 M
Stock-Based Compensation 285 K
Change in Working Capital -1.42 M
Others -2.59 M
Free Cash Flow 5.08 M
3. WALL STREET ANALYSTS ESTIMATES
Wall Street Analysts Price Targets Materialise NV
image
MTLS has no price targets from Wall Street.
4. DIVIDEND ANALYSIS
5. COMPETITION
slide 2 of 8
6. Ownership
Insider Ownership Materialise NV
image
Sold
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
0 USD 0
Bought
0 USD 0
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
7. News
Materialise to Hold Annual Shareholders' Meeting and Extraordinary Shareholders' Meeting on June 3, 2025 LEUVEN, Belgium, May 16, 2025 (GLOBE NEWSWIRE) -- Materialise NV (NASDAQ:MTLS), a leading provider of additive manufacturing software and sophisticated 3D printing solutions, today announced that it will host its Annual General Shareholders' Meeting (AGM) on Tuesday, June 3, 2025, at 10:00 am CET. globenewswire.com - 1 month ago
Materialise: Medical Segment Continues To Thrive While Materialise's Q1 results were mixed they exceeded low investor expectations, with the company's Medical segment continuing to excel. Market conditions are likely to remain challenging, but lower energy costs and increased defense spending in Europe could help to offset this. Materialise's Medical segment alone more than justifies its current market capitalization. seekingalpha.com - 1 month ago
Materialise NV (MTLS) Q1 2025 Earnings Call Transcript Materialise NV (NASDAQ:MTLS ) Q1 2025 Earnings Conference Call April 24, 2025 8:30 AM ET Company Participants Harriet Fried - Alliance Advisors, IR Brigitte de Vet - Chief Executive Officer Koen Berges - Chief Financial Officer Conference Call Participants Troy Jensen - Cantor Fitzgerald Operator Good day and thank you for standing by. Welcome to the First Quarter 2025 Materialise Financial Results Conference Call. seekingalpha.com - 1 month ago
Materialise Reports First Quarter 2025 Results LEUVEN, Belgium--(BUSINESS WIRE)--Materialise NV (NASDAQ:MTLS), a leading provider of additive manufacturing and medical software and of sophisticated 3D printing services, today announced its financial results for the first quarter ended March 31, 2025. Highlights – First Quarter 2025 Boosted by 18.7% growth in our Materialise Medical segment, total revenue increased by 4.3% to 66,379 kEUR for the first quarter of 2025 compared to the corresponding 2024 period. Total deferred revenues from sof. businesswire.com - 1 month ago
Materialise NV to Report First Quarter 2025 Earnings on Thursday, April 24, 2025 LEUVEN, Belgium--(BUSINESS WIRE)--Materialise NV (NASDAQ: MTLS), a leading provider of additive manufacturing software and of sophisticated 3D printing services, today announced that it will release financial results for the first quarter ended March 31, 2025 on Thursday, April 24, 2025 at 6:30 a.m. ET/12:30 p.m. CET. Senior management will hold a conference call to discuss the first quarter 2025 financial results on Thursday, April 24, 2025 at 8:30 a.m. ET/2:30 p.m. CET. To access the call by. businesswire.com - 2 months ago
Materialise: Manufacturing Headwinds Are A Distraction Materialise: Manufacturing Headwinds Are A Distraction seekingalpha.com - 3 months ago
Materialise NV (MTLS) Q4 2024 Earnings Call Transcript Materialise NV (NASDAQ:MTLS ) Q4 2024 Earnings Conference Call February 20, 2025 8:30 AM ET Company Participants Harriet Fried - Investor Relations Brigitte de Vet-Veithen - Chief Executive Officer Koen Berges - Chief Financial Officer Conference Call Participants Alexander Craeymeersch - Kepler Cheuvreux Troy Jensen - Cantor Fitzgerald Operator Ladies and gentlemen thank you for standing by. Welcome to the Fourth Quarter 2024 Materialise Financial Results Conference Call. seekingalpha.com - 3 months ago
Materialise Reports Fourth Quarter and Full Year 2024 Results LEUVEN, Belgium--(BUSINESS WIRE)--Materialise NV (NASDAQ:MTLS), a leading provider of additive manufacturing and medical software solutions and of sophisticated 3D printing services, today announced its financial results for the fourth quarter and full year ended December 31, 2024. Highlights – Fourth Quarter 2024 Total revenue increased 0.6% to 65,680 kEUR for the fourth quarter of 2024 from 65,295 kEUR for the corresponding 2023 period boosted by 14.3% growth in our Materialise Medical segmen. businesswire.com - 3 months ago
Materialise NV to Report Fourth Quarter 2024 Earnings on Thursday, February 20, 2025 LEUVEN, Belgium--(BUSINESS WIRE)--Materialise NV (NASDAQ: MTLS), a leading provider of additive manufacturing software and of sophisticated 3D printing services, today announced that it will release financial results for the fourth quarter ended December 31, 2024 on Thursday, February 20, 2025 at 6:30 a.m. ET/12:30 p.m. CET. Senior management will hold a conference call to discuss the fourth quarter 2024 financial results on Thursday, February 20, 2025 at 8:30 a.m. ET/2:30 p.m. CET. To access t. businesswire.com - 4 months ago
Materialise (MTLS) Is a Great Choice for 'Trend' Investors, Here's Why Materialise (MTLS) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passed through our shorter-term trading strategy-based screen. zacks.com - 6 months ago
Should Value Investors Buy Materialise (MTLS) Stock? Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks. zacks.com - 6 months ago
Here's Why Momentum in Materialise (MTLS) Should Keep going Materialise (MTLS) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move. zacks.com - 6 months ago
8. Profile Summary

Materialise NV MTLS

image
COUNTRY BE
INDUSTRY Software - Application
MARKET CAP $ 330 M
Dividend Yield 0.00%
Description Materialise NV provides additive manufacturing and medical software, and 3D printing services in the Americas, Europe and Africa, and the Asia-Pacific. The company operates through three segments: Materialise Software, Materialise Medical, and Materialise Manufacturing. Its Materialise Software segment offers software through programs and platforms that enable and enhance the functionality of 3D printers and of 3D printing operations. Its software interfaces between various types of 3D printers; and various software applications and capturing technologies, including computer-aided design/computer-aided manufacturing packages and 3D scanners. This segment serves 3D printing machine manufacturers; production companies and contract manufacturers in automotive, aerospace, consumer goods, and hearing aid industries; and 3D printing service bureaus through its sales force, Website, and third-party distributors. The company's Materialise Medical segment provides medical software that allows medical-image based analysis and engineering, as well as patient-specific design of surgical devices and implants. It serves medical device companies, hospitals, universities, research institutes, and industrial companies through its direct sales force, Website, and picture archiving and communication system partners. Its Materialise Manufacturing segment provides 3D printing services, design and engineering services, and rapid prototyping and additive manufacturing of production parts to industrial and commercial customers. The company has collaboration agreements with Zimmer Biomet Holdings, Inc.; Encore Medical, L.P.; DePuy Synthes Companies of Johnson & Johnson; Limacorporate Spa; Mathys AG; Corin Ltd; Medtronic Inc.; and Abbott Laboratories Inc. Materialise NV was incorporated in 1990 and is headquartered in Leuven, Belgium.
Contact Technologielaan 15, Leuven, 3001 https://www.materialise.com
IPO Date June 25, 2014
Employees 488
Officers Ms. Brigitte de Vet-Veithen Chief Executive Officer Mr. Koen Peters Executive Vice President of Medical Mr. Udo Eberlein Executive Vice President of Software Mr. Wilfried Vancraen Founder & Chairman Mr. Johan Pauwels Executive Vice President & Chief Operating Officer Mr. Koen Berges Chief Financial Officer Mr. Bart Van der Schueren Chief Strategy & Technology Officer and Executive Vice President Ms. Conny Hooghe Global HR Director Mr. Jurgen Laudus Executive Vice President of Manufacturing Ms. Carla Van Steenbergen Director of Corporate Affairs, Vice President, Compliance Officer & Secretary